NO20090692L - Farmasoytiske og kostholdsprodukter som omfatter vitamin K2 - Google Patents
Farmasoytiske og kostholdsprodukter som omfatter vitamin K2Info
- Publication number
- NO20090692L NO20090692L NO20090692A NO20090692A NO20090692L NO 20090692 L NO20090692 L NO 20090692L NO 20090692 A NO20090692 A NO 20090692A NO 20090692 A NO20090692 A NO 20090692A NO 20090692 L NO20090692 L NO 20090692L
- Authority
- NO
- Norway
- Prior art keywords
- vitamin
- pharmaceutical
- oil
- compounds
- class
- Prior art date
Links
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 title abstract 6
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 title abstract 5
- 235000019143 vitamin K2 Nutrition 0.000 title abstract 3
- 239000011728 vitamin K2 Substances 0.000 title abstract 3
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 6
- 235000019198 oils Nutrition 0.000 abstract 3
- 229940106134 krill oil Drugs 0.000 abstract 2
- 239000011700 menaquinone-7 Substances 0.000 abstract 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 2
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 235000021323 fish oil Nutrition 0.000 abstract 1
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
Abstract
Et farmasøytisk og nutrasøytisk produkt er tilveiebrakt som innbefatter vitamin K2 eller en forbindelse innenfor vitamin K2 klassen av forbindelser, eventuelt og fortrinnsvis i kombinasjon med en eller flere flerumettede fettsyrer, enten i renset form eller som en marin olje (dvs. fiske- og/eller krillolje). Også tilveiebrakt er anvendelsen av vitamin K2 eller en forbindelse innenfor vitamin K2 klassen av forbindelser, fortrinnsvis i kombinasjon med en eller flere flerumettede fettsyrer, enten i renset form eller som en marin olje, ved behandling eller profylakse av forstyrrelser relatert til ben, brusk og det kardiovaskulære systemet. Foretrukne forbindelser innenfor vitamin K2 klassen av forbindelser er MK-7, MK-8, MK-9 og MK-10, særlig MK-7 eller MK-9. Den marine oljen er foretrukket krillolje eller fiskeolje.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20090692A NO343923B1 (no) | 2006-07-14 | 2009-02-12 | Farmasøytiske og nutrasøytiske produkter som innbefatter minst en forbindelse innenfor vitamin K2 klassen og slike produkter for forebygging eller terapi av forstyrrelser relatert til ben, brusk og det kardiovaskulære systemet. |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20063291 | 2006-07-14 | ||
NO20063292 | 2006-07-14 | ||
NO20063988 | 2006-09-06 | ||
PCT/EP2007/006241 WO2008006607A2 (en) | 2006-07-14 | 2007-07-13 | Pharmaceutical and nutraceutical products comprising vitamin k2 |
NO20090692A NO343923B1 (no) | 2006-07-14 | 2009-02-12 | Farmasøytiske og nutrasøytiske produkter som innbefatter minst en forbindelse innenfor vitamin K2 klassen og slike produkter for forebygging eller terapi av forstyrrelser relatert til ben, brusk og det kardiovaskulære systemet. |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20090692L true NO20090692L (no) | 2009-04-01 |
NO343923B1 NO343923B1 (no) | 2019-07-08 |
Family
ID=38820269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090692A NO343923B1 (no) | 2006-07-14 | 2009-02-12 | Farmasøytiske og nutrasøytiske produkter som innbefatter minst en forbindelse innenfor vitamin K2 klassen og slike produkter for forebygging eller terapi av forstyrrelser relatert til ben, brusk og det kardiovaskulære systemet. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20100048704A1 (no) |
EP (1) | EP2046312B1 (no) |
JP (2) | JP5827784B2 (no) |
AU (1) | AU2007271900B2 (no) |
CA (1) | CA2657748C (no) |
ES (1) | ES2790590T3 (no) |
NO (1) | NO343923B1 (no) |
NZ (1) | NZ574882A (no) |
PL (1) | PL2046312T3 (no) |
WO (1) | WO2008006607A2 (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8697138B2 (en) | 2007-03-28 | 2014-04-15 | Aker Biomarine As | Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
EP2612672A1 (en) | 2007-03-28 | 2013-07-10 | Aker BioMarine AS | Bioeffective krill oil compositions |
US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
NL1034964C2 (nl) * | 2008-01-28 | 2009-07-30 | Friesland Brands Bv | Werkwijze en composities voor de behandeling van botaandoeningen. |
GB0817701D0 (en) * | 2008-09-26 | 2008-11-05 | Omegatri As | Krill oil powder and krill oil tablets |
US8372812B2 (en) | 2009-02-26 | 2013-02-12 | Aker Biomarine Asa | Phospholipid and protein tablets |
FR2949044B1 (fr) * | 2009-08-12 | 2021-05-07 | Expanscience Lab | Composition comprenant une fraction d'insaponifiable |
CA2773957C (en) | 2009-09-14 | 2018-01-09 | Nestec S.A. | Nutritional compositions for modulating inflammation including exogenous vitamin k2 |
GB2476644B (en) * | 2009-12-23 | 2012-11-14 | Haomamedica Ltd | 1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis |
EP2601168A4 (en) * | 2010-08-06 | 2013-12-04 | Ampere Life Sciences Inc | TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K |
AU2011324792A1 (en) * | 2010-11-01 | 2013-05-30 | Viridis Biopharma Pvt. Ltd | Dynamic balancing of autonomic nervous system through vitamin MK-7 |
NL2008294C2 (en) * | 2011-05-20 | 2013-08-19 | Friesland Brands Bv | Food composition comprising vitamin k and saturated fat. |
WO2012161572A1 (en) * | 2011-05-20 | 2012-11-29 | Friesland Brands B.V. | Composition comprising vitamin k2 |
AU2014203179C1 (en) | 2013-06-14 | 2017-05-04 | Aker Biomarine Antarctic As | Lipid extraction processes |
EP2886129A1 (en) | 2013-12-20 | 2015-06-24 | VitaK B.V. | Prevention and counteraction of diet-induced thrombosis risk |
GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
RU2718983C2 (ru) | 2015-02-11 | 2020-04-15 | Акер Биомарин Антарктик Ас | Композиции липидов |
WO2016128830A1 (en) | 2015-02-11 | 2016-08-18 | Aker Biomarine Antarctic As | Lipid extraction processes |
EP3359130A4 (en) * | 2015-10-09 | 2019-05-01 | Combocap, Inc. | CAPSULE WITH VOLUME ADJUSTABLE INTERNAL MEMBRANE |
WO2019191773A1 (en) | 2018-03-30 | 2019-10-03 | Kaydence Pharma As | Rapidly improving vascular conditions by administering vitamin k |
WO2019237053A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating tissue calcification |
SG11202012055PA (en) * | 2018-06-08 | 2021-01-28 | Epizon Pharma Inc | Methods and compositions for preventing or treating calciphylaxis |
WO2021165859A1 (en) * | 2020-02-19 | 2021-08-26 | Yogesh Dound | A composition comprising vitamin k2-7 in combination with vitamin k-1 in purest form |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1176916B (it) * | 1984-10-10 | 1987-08-18 | Elvira Pistolesi | Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica |
JP2577584B2 (ja) * | 1987-11-13 | 1997-02-05 | 雪印乳業株式会社 | 多価不飽和脂肪酸とビタミンaを含有する組成物の保存方法 |
US5180747A (en) * | 1989-02-28 | 1993-01-19 | Nisshin Flour Milling Co., Ltd. | Stabilized fat-soluble vitamin compositions |
JPH03254658A (ja) * | 1990-03-01 | 1991-11-13 | Binshiyoo:Kk | 納豆によるスナック食品の製造法 |
JPH04253908A (ja) * | 1990-12-28 | 1992-09-09 | Nippon Oil & Fats Co Ltd | 骨粗鬆症治療薬 |
JP3092180B2 (ja) * | 1991-02-27 | 2000-09-25 | 日本油脂株式会社 | 低密度リポ蛋白受容体活性化剤 |
IT1274734B (it) * | 1994-08-25 | 1997-07-24 | Prospa Bv | Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti |
GB9713620D0 (en) | 1997-06-28 | 1997-09-03 | Boots Co Plc | Composition |
GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
US7226916B1 (en) * | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
DE60128179T2 (de) * | 2000-05-12 | 2008-01-10 | Nattopharma Asa | Nahrungsmittel enthaltend Vitamin k2 |
GB0016452D0 (en) * | 2000-07-04 | 2000-08-23 | Kilgowan Limited | Vitamin K and essential fatty acids |
KR100875800B1 (ko) * | 2001-03-15 | 2008-12-24 | 디에스엠 아이피 어셋츠 비.브이. | 이소플라본과 다가 불포화 지방산의 혼합물을 포함하는골다공증 예방용 조성물 |
US20040241249A1 (en) * | 2001-06-18 | 2004-12-02 | Tina Sampalis | Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
EP1455725B1 (en) * | 2001-10-09 | 2006-08-02 | Research Foundation of Suny | Apparatus for treating orthostatic hypotension |
JP2003169632A (ja) * | 2001-12-08 | 2003-06-17 | Sapuri:Kk | 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品 |
JP2003313142A (ja) * | 2002-02-20 | 2003-11-06 | En Otsuka Pharmaceutical Co Ltd | 栄養組成物 |
JP3999532B2 (ja) * | 2002-02-26 | 2007-10-31 | 三菱重工業株式会社 | 輸送用冷凍装置 |
GB0210212D0 (en) * | 2002-05-03 | 2002-06-12 | Univ Southampton | Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability |
GB0220182D0 (en) * | 2002-08-30 | 2002-10-09 | Cardiovascular Res Inst Maastr | Organic compounds |
WO2005030190A1 (en) * | 2003-09-26 | 2005-04-07 | Natural Asa | Natural menaquinone 7 compositions |
JP2005237300A (ja) * | 2004-02-26 | 2005-09-08 | Aichi Prefecture | 食品素材及びその製造方法 |
-
2007
- 2007-07-13 JP JP2009519843A patent/JP5827784B2/ja active Active
- 2007-07-13 EP EP07765188.3A patent/EP2046312B1/en active Active
- 2007-07-13 CA CA2657748A patent/CA2657748C/en active Active
- 2007-07-13 ES ES07765188T patent/ES2790590T3/es active Active
- 2007-07-13 AU AU2007271900A patent/AU2007271900B2/en active Active
- 2007-07-13 PL PL07765188T patent/PL2046312T3/pl unknown
- 2007-07-13 NZ NZ574882A patent/NZ574882A/xx unknown
- 2007-07-13 US US12/373,601 patent/US20100048704A1/en active Pending
- 2007-07-13 WO PCT/EP2007/006241 patent/WO2008006607A2/en active Application Filing
-
2009
- 2009-02-12 NO NO20090692A patent/NO343923B1/no unknown
-
2013
- 2013-11-05 JP JP2013229593A patent/JP2014031378A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2046312B1 (en) | 2020-02-19 |
WO2008006607A3 (en) | 2008-10-23 |
US20100048704A1 (en) | 2010-02-25 |
CA2657748A1 (en) | 2008-01-17 |
WO2008006607A2 (en) | 2008-01-17 |
AU2007271900B2 (en) | 2013-05-23 |
NZ574882A (en) | 2012-08-31 |
JP2014031378A (ja) | 2014-02-20 |
EP2046312A2 (en) | 2009-04-15 |
NO343923B1 (no) | 2019-07-08 |
CA2657748C (en) | 2014-10-21 |
AU2007271900A1 (en) | 2008-01-17 |
JP5827784B2 (ja) | 2015-12-02 |
JP2009544590A (ja) | 2009-12-17 |
PL2046312T3 (pl) | 2021-02-08 |
ES2790590T3 (es) | 2020-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090692L (no) | Farmasoytiske og kostholdsprodukter som omfatter vitamin K2 | |
WO2007136762A3 (en) | Production of fatty acids and derivatives thereof | |
NO20074318L (no) | Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer | |
EP3623465A3 (en) | Production of fatty acids and derivatives thereof | |
WO2009099830A3 (en) | Edible film-strips for immediate release of active ingredients | |
WO2008129358A3 (en) | Oil producing microbes and methods of modification thereof | |
HK1136283A1 (en) | Compounds for the prevention and treatment of cardiovascular diseases | |
WO2009013596A3 (en) | Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products | |
CL2012002013A1 (es) | Microorganismos aislado thrastochytrium sp. atcc pta-10212 util en la produccion de acidos grasos omega-3 | |
WO2010079431A3 (en) | Compounds for the prevention and treatment of cardiovascular disease | |
RS20050395A (en) | Ppar activators | |
WO2008036653A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
WO2008036642A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
WO2010136900A3 (en) | Methods of using krill oil to treat risk factors for metabolic disorders and obesity | |
WO2011097276A8 (en) | Methods and compositions for treating arthritis with docosahexaenoic acid | |
WO2007053815A3 (en) | Compositions and methods for organic juice based skin care products | |
WO2006123031A3 (fr) | Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l’un de ses derives a l'etat solubilise | |
WO2013116753A8 (en) | Fatty acids as anti-inflammatory agents | |
ATE530526T1 (de) | Lactam-substituierte dicarbonsäuren und ihre verwendung | |
EP2506848A4 (en) | SUBSTANCES TO REDUCE THE IMPACT OF HARD CARDIAL EVENTS CONTAINING AN EXTRACT OF RED FERMENTED RICE AND A MULTIPLE UNSATURATED OMEGA-3 FATTY ACID OR DERIVATIVES THEREOF | |
DE602006011127D1 (de) | Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür | |
TW200612903A (en) | Use of trisubstituted benzopyranones | |
MXPA05012570A (es) | Derivados de tetrahidroisoquinolina como activadores de ppar-a. | |
MY181997A (en) | Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid | |
WO2005076761A3 (en) | Composition for preenting a cold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: PHARMACO AS, NO |
|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: NATTOPHARMA AS, NO |
|
CREP | Change of representative |